Interferon-gamma Release Tests: Clinical Trials

5 trials of Interferon-gamma Release Tests, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Completed 1

Follow Interferon-gamma Release Tests: new trials by email Literature Review of Interferon-gamma Release Tests trials Research Report on Interferon-gamma Release Tests

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT
Ultra low dose chest computed tomography (ULDCT), Chest X-ray, Interferon-gamma Release Assay (IGRA) - Tuberculosis, Pulmonary, Latent Tuberculosis
Not applicableUnknownSeoul National University Hospital1162017-06-202017-07-21
Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment
Interferon gamma release assay (IGRA) - Tuberculosis
UnknownPaola Mantegani2202017-01-272024-09-26
Impact of A. Lumbricoides on Pulmonary Aspergillosis Development
Interleukin-1B, Interleukin-4, Interleukin-6 - COPD Exacerbation Acute, Ascaris Lumbricoides Infection
Not applicableUnknownResearch Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan2002015-05-012023-08-01
Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults
Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA) - Latent Tuberculosis
Not applicableCompletedSheba Medical Center1152014-03-012019-01-25
Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children
Interferon-Gamma Release Assay, RT-23 - Tuberculosis, HIV
CompletedCase Western Reserve University5642009-01-262022-01-18

Conditions studied

Latent Tuberculosis (2)  ·  Tuberculosis (2)  ·  Ascariasis (1)  ·  Aspergillosis (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Tuberculosis, Pulmonary (1)

Sponsors

Case Western Reserve University (1)  ·  Paola Mantegani (1)  ·  Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan (1)  ·  Seoul National University Hospital (1)  ·  Sheba Medical Center (1)

Countries

Israel (1)  ·  Italy (1)  ·  South Africa (1)  ·  South Korea (1)  ·  Uzbekistan (1)

Top investigators

Daniela M Cirillo, MD,PhD (1)  ·  Jae-Joon Yim, MD, PhD (1)

Results publications

PMID 19383198, PMID 19880906, PMID 22936710, PMID 24454900, PMID 24788998, PMID 25265362

NIH funding

R01AI076199 (1)